Nisa Investment Advisors’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,309
| Closed | -$61.5K | – | 3084 |
|
|
2025
Q2 | $61.5K | Buy |
1,309
+548
| +72% | +$24.4K | ﹤0.01% | 1542 |
|
|
2025
Q1 | $33.6K | Sell |
761
-76
| -9% | -$3.5K | ﹤0.01% | 1711 |
|
|
2024
Q4 | $30.2K | Buy |
837
+160
| +24% | +$5.59K | ﹤0.01% | 1807 |
|
|
2024
Q3 | $21.7K | Buy |
677
+35
| +5% | +$1.31K | ﹤0.01% | 1885 |
|
|
2024
Q2 | $24.2K | Buy |
642
+72
| +13% | +$3.03K | ﹤0.01% | 1879 |
|
|
2024
Q1 | $28.1K | Buy |
570
+58
| +11% | +$2.68K | ﹤0.01% | 1791 |
|
|
2023
Q4 | $18.7K | Sell |
512
-1,310
| -72% | -$34.2K | ﹤0.01% | 1902 |
|
|
2023
Q3 | $42.1K | Buy |
1,822
+1
| +0.1% | +$27 | ﹤0.01% | 1774 |
|
|
2023
Q2 | $47.7K | Buy |
1,821
+21
| +1% | +$552 | ﹤0.01% | 1762 |
|
|
2023
Q1 | $46K | Hold |
1,800
| – | – | ﹤0.01% | 1743 |
|
|
2022
Q4 | $47K | Sell |
1,800
-7
| -0.4% | -$172 | ﹤0.01% | 1797 |
|
|
2022
Q3 | $43K | Buy |
1,807
+27
| +2% | +$774 | ﹤0.01% | 1801 |
|
|
2022
Q2 | $44K | Buy |
1,780
+920
| +107% | +$33.6K | ﹤0.01% | 1770 |
|
|
2022
Q1 | $49K | Sell |
860
-420
| -33% | -$24K | ﹤0.01% | 1852 |
|
|
2021
Q4 | $71K | Sell |
1,280
-640
| -33% | -$42.4K | ﹤0.01% | 1630 |
|
|
2021
Q3 | $122 | Hold |
1,920
| – | – | ﹤0.01% | 1608 |
|
|
2021
Q2 | $158 | Buy |
1,920
+420
| +28% | +$31.9K | ﹤0.01% | 1495 |
|
|
2021
Q1 | $110 | Hold |
1,500
| – | – | ﹤0.01% | 1715 |
|
|
2020
Q4 | $109K | Buy |
1,500
+500
| +50% | +$32.2K | ﹤0.01% | 1701 |
|
|
2020
Q3 | $48K | Buy |
+1,000
| New | +$42.6K | ﹤0.01% | 1826 |
|
Other funds holding SWTX
Nisa Investment Advisors's SWTX Position: Q3 2025 in Review
Nisa Investment Advisors sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 1,309 shares — an estimated $61.5K sold.
Nisa Investment Advisors first reported a position in SWTX in Q3 2020 and held it in 20 quarters. The position peaked at $109K in Q4 2020. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Nisa Investment Advisors reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Nisa Investment Advisors sold 1,309 SpringWorks Therapeutics shares in Q3 2025, an estimated $61.5K.
- Nisa Investment Advisors first reported a position in SpringWorks Therapeutics in Q3 2020 and held it in 20 quarters.
- Nisa Investment Advisors's SpringWorks Therapeutics position peaked at $109K in Q4 2020.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.